Advertisement

Buy track record

How this insider's open-market purchases have performed
100%
of buys now in profit
2 up · 0 down
Avg return since buy+307.8%
Median return+307.8%
Best trade+490.4%
Worst trade+125.2%
Buys scored2
Average return by holding period — separates good entry timing from riding one long winner
After 1 month +11.6% 100% won · 2 trades
After 3 months +12.5% 100% won · 2 trades
After 6 months +14.7% 100% won · 2 trades
After 12 months +2.7% 100% won · 2 trades
DateCompany90d trendBuy priceValueΔOwn1M3M6M12MTo date
Nov 17, 2020 TEN $9 $200.7K NEW +16.3% +22.2% +17.7% +4.0% +490.4%
Nov 1, 2018 BDC $53 $494.3K NEW +6.8% +2.8% +11.6% +1.5% +125.2%
How this is calculated. We score only open-market purchases (SEC code P) — the buys that carry real signal. Each trade's return is measured from the adjusted closing price on the purchase date to the latest close, accounting for stock splits and dividends. The 1M/3M/6M/12M columns show the same trade's return after each fixed holding period; a dash means that horizon hasn't elapsed yet or isn't priceable. Sales are excluded because insiders sell for many routine reasons. With only 2 scored trades, treat this as a small sample, not a verdict.
Advertisement
Open-market buys
$694.9K
2 trades
Open-market sells
$4.41M
8 trades
Net flow
−$3.72M
Net selling
Total filings
40
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
TEN
Disposition to issuer Stroup John S · Director · Disposition to issuer · filed Nov 21, 2022 ΔOwn −100%
−$610.5K
30,526 sh @ $20
TEN
Disposition to issuer Stroup John S · Director · Disposition to issuer · filed Nov 21, 2022 ΔOwn −100%
−$452.5K
22,623 sh @ $20
Advertisement
RXN
Grant/award Stroup John S · Director · Grant/award · filed Sep 9, 2021 ΔOwn +25%
+$302.5K
10,320 sh @ $29
RXN
Sell Stroup John S · Director · Open-market sale · filed Sep 9, 2021 ΔOwn −20%

Stroup John S sold $650.9K of RXN, trimming their stake 20%.

−$650.9K
10,320 sh @ $63
BDC
Sell Stroup John S · Director, Executive Chairman · Open-market sale · filed Dec 21, 2020 ΔOwn −7.4%

Stroup John S sold $298.3K of BDC, trimming their stake 7%.

−$298.3K
7,417 sh @ $40
BDC
Sell Stroup John S · Director, Executive Chairman · Open-market sale · filed Dec 21, 2020 ΔOwn −20%

Stroup John S sold $867K of BDC, trimming their stake 20%.

−$867K
21,713 sh @ $40
BDC
Sell Stroup John S · Director, Executive Chairman · Open-market sale · filed Dec 21, 2020 ΔOwn −100%

Stroup John S sold $377.1K of BDC, trimming their stake 100%.

−$377.1K
9,250 sh @ $41
TEN
Buy Stroup John S · Director · Open-market purchase · filed Nov 18, 2020 ΔOwn NEW

Stroup John S, TEN's Director, spent $200.7K of their own money on 22,623 shares at $9, opening a brand-new position.

+$200.7K
22,623 sh @ $9
BDC
Grant/award Stroup John S · Director, Executive Chairman · Grant/award · filed Jul 6, 2020 ΔOwn +5.7%
+$0
5,405 sh
BDC
Grant/award Stroup John S · Director, Chairman, President and CEO · Grant/award · filed Feb 12, 2020 ΔOwn +96%
+$0
46,218 sh
RXN
Option exercise Stroup John S · Director · Option exercise · filed Jan 31, 2020 ΔOwn +36%
+$247.8K
11,250 sh @ $22
RXN
Sell Stroup John S · Director · Open-market sale · filed Jan 31, 2020 ΔOwn −27%

Stroup John S sold $377K of RXN, trimming their stake 27%.

−$377K
11,250 sh @ $34
RXN
Option exercise Stroup John S · Director · Option exercise · filed Jan 31, 2020 ΔOwn +37%
+$217.9K
11,470 sh @ $19
RXN
Sell Stroup John S · Director · Open-market sale · filed Jan 31, 2020 ΔOwn −27%

Stroup John S sold $384.3K of RXN, trimming their stake 27%.

−$384.3K
11,470 sh @ $34
BDC
Grant/award Stroup John S · Director, Chairman, President and CEO · Grant/award · filed Mar 5, 2019 ΔOwn +548%
+$0
40,630 sh
BDC
Grant/award Stroup John S · Director, Chairman, President and CEO · Grant/award · filed Feb 26, 2019 ΔOwn NEW
+$0
7,417 sh
BDC
Buy Stroup John S · Director, Chairman, President and CEO · Open-market purchase · filed Nov 2, 2018 ΔOwn NEW

Stroup John S, BDC's CEO, spent $494.3K of their own money on 9,250 shares at $53, opening a brand-new position.

+$494.3K
9,250 sh @ $53
RXN
Grant/award Stroup John S · Director · Grant/award · filed Apr 17, 2018 ΔOwn +3.4%
+$22.5K
745 sh @ $30

Frequently asked questions

How is Stroup John S's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Stroup John S's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.